{"total":10,"page":1,"pageSize":25,"pages":1,"millis":13,"query":{"q":"\u0022Secretary of Health and Human Services\u0022","state":"","metro":"","industry":"","agency":"FED-HEALTH-OTHER","kind":"","level":"","type":"","quarter":"","grade":"","collection":"","from":"","to":"","sort":"relevance"},"items":[{"id":"AGY-FED-HEALTH-OTHER-038","kind":"order","level":"federal","jurisdiction":"United States (federal); Department of Health and Human Services, Office of the Secretary","state":"","metro":"","industry":"","agency":"FED-HEALTH-OTHER","collection":"AGY-FED-HEALTH-OTHER","issuer":"Alex M. Azar II, Secretary of Health and Human Services","instrument":"Determination of Public Health Emergency and Declaration that circumstances exist justifying emergency use of in vitro diagnostics, 85 Fed. Reg. 7316 (Feb. 7, 2020)","title":"Determination of Public Health Emergency","dateIssued":"2020-02-04","startDate":"2020-02-04","endDate":"2021-09-30","quarters":["2020Q2","2020Q3","2020Q4","2021Q1","2021Q2","2021Q3"],"types":["EMER","SUPPLY"],"grade":"primary","fileExists":true,"url":"/library/AGY-FED-HEALTH-OTHER-038","exhibitUrl":"/exhibit/AGY-FED-HEALTH-OTHER-038"},{"id":"AGY-FED-HEALTH-OTHER-118","kind":"order","level":"federal","jurisdiction":"United States (federal); Department of Health and Human Services (Health Resources and Services Administration administering the Provider Relief Fund)","state":"","metro":"","industry":"","agency":"FED-HEALTH-OTHER","collection":"AGY-FED-HEALTH-OTHER","issuer":"Secretary of Health and Human Services (terms administered by HRSA)","instrument":"Provider Relief Fund, Acceptance of Terms and Conditions, Relief Fund Payment from Initial $30 Billion General Distribution","title":"Acceptance of Terms and Conditions - Relief Fund Payment from Initial $30 Billion General Distribution","dateIssued":"2020-04-10","startDate":"2020-04-10","endDate":"2021-09-30","quarters":["2020Q2","2020Q3","2020Q4","2021Q1","2021Q2","2021Q3"],"types":["HC","OTHER"],"grade":"primary","fileExists":true,"url":"/library/AGY-FED-HEALTH-OTHER-118","exhibitUrl":"/exhibit/AGY-FED-HEALTH-OTHER-118"},{"id":"AGY-FED-HEALTH-OTHER-040","kind":"order","level":"federal","jurisdiction":"United States (federal); Department of Health and Human Services, Office of the Secretary","state":"","metro":"","industry":"","agency":"FED-HEALTH-OTHER","collection":"AGY-FED-HEALTH-OTHER","issuer":"Alex M. Azar II, Secretary of Health and Human Services","instrument":"Declaration Under the Public Readiness and Emergency Preparedness Act for Medical Countermeasures Against COVID-19, 85 Fed. Reg. 15198 (Mar. 17, 2020)","title":"Declaration Under the Public Readiness and Emergency Preparedness Act for Medical Countermeasures Against COVID-19","dateIssued":"2020-03-10","startDate":"2020-02-04","endDate":"2020-10-20","quarters":["2020Q2","2020Q3","2020Q4","2021Q1","2021Q2","2021Q3"],"types":["HC","EMER","OTHER"],"grade":"primary","fileExists":true,"url":"/library/AGY-FED-HEALTH-OTHER-040","exhibitUrl":"/exhibit/AGY-FED-HEALTH-OTHER-040"},{"id":"AGY-FED-HEALTH-OTHER-036","kind":"order","level":"federal","jurisdiction":"United States (federal); Department of Health and Human Services, Office of the Secretary","state":"","metro":"","industry":"","agency":"FED-HEALTH-OTHER","collection":"AGY-FED-HEALTH-OTHER","issuer":"Alex M. Azar II, Secretary of Health and Human Services","instrument":"Emergency Use Authorization Declaration (medical devices, including alternative products used as medical devices), 85 Fed. Reg. 17335 (Mar. 27, 2020)","title":"Emergency Use Authorization Declaration","dateIssued":"2020-03-24","startDate":"2020-03-24","endDate":"2021-09-30","quarters":["2020Q2","2020Q3","2020Q4","2021Q1","2021Q2","2021Q3"],"types":["SUPPLY","EMER"],"grade":"primary","fileExists":true,"url":"/library/AGY-FED-HEALTH-OTHER-036","exhibitUrl":"/exhibit/AGY-FED-HEALTH-OTHER-036"},{"id":"AGY-FED-HEALTH-OTHER-037","kind":"order","level":"federal","jurisdiction":"United States (federal); Department of Health and Human Services, Office of the Secretary","state":"","metro":"","industry":"","agency":"FED-HEALTH-OTHER","collection":"AGY-FED-HEALTH-OTHER","issuer":"Alex M. Azar II, Secretary of Health and Human Services","instrument":"Emergency Use Authorization Declaration (drugs and biological products), 85 Fed. Reg. 18250 (Apr. 1, 2020)","title":"Emergency Use Authorization Declaration","dateIssued":"2020-03-27","startDate":"2020-03-27","endDate":"2021-09-30","quarters":["2020Q2","2020Q3","2020Q4","2021Q1","2021Q2","2021Q3"],"types":["SUPPLY","EMER"],"grade":"primary","fileExists":true,"url":"/library/AGY-FED-HEALTH-OTHER-037","exhibitUrl":"/exhibit/AGY-FED-HEALTH-OTHER-037"},{"id":"AGY-FED-HEALTH-OTHER-039","kind":"order","level":"federal","jurisdiction":"United States (federal); Department of Health and Human Services, Office of the Secretary","state":"","metro":"","industry":"","agency":"FED-HEALTH-OTHER","collection":"AGY-FED-HEALTH-OTHER","issuer":"Alex M. Azar II, Secretary of Health and Human Services","instrument":"Emergency Use Declaration (personal respiratory protective devices), 85 Fed. Reg. 13907 (Mar. 10, 2020)","title":"Emergency Use Declaration","dateIssued":"2020-03-02","startDate":"2020-03-02","endDate":"2021-09-30","quarters":["2020Q2","2020Q3","2020Q4","2021Q1","2021Q2","2021Q3"],"types":["SUPPLY","EMER"],"grade":"primary","fileExists":true,"url":"/library/AGY-FED-HEALTH-OTHER-039","exhibitUrl":"/exhibit/AGY-FED-HEALTH-OTHER-039"},{"id":"AGY-FED-HEALTH-OTHER-015","kind":"order","level":"federal","jurisdiction":"United States (federal); Drug Enforcement Administration, Diversion Control Division","state":"","metro":"","industry":"","agency":"FED-HEALTH-OTHER","collection":"AGY-FED-HEALTH-OTHER","issuer":"Drug Enforcement Administration, Diversion Control Division","instrument":"DEA-DC-023 (DEA075), How to Prescribe Controlled Substances to Patients During the COVID-19 Public Health Emergency (decision tree)","title":"How to Prescribe Controlled Substances to Patients During the COVID-19 Public Health Emergency","dateIssued":"2020-03-31","startDate":"2020-03-31","endDate":"2021-09-30","quarters":["2020Q2","2020Q3","2020Q4","2021Q1","2021Q2","2021Q3"],"types":["HC","TELE","OTHER"],"grade":"primary","fileExists":true,"url":"/library/AGY-FED-HEALTH-OTHER-015","exhibitUrl":"/exhibit/AGY-FED-HEALTH-OTHER-015"},{"id":"AGY-FED-HEALTH-OTHER-032","kind":"order","level":"federal","jurisdiction":"United States (federal); Food and Drug Administration","state":"","metro":"","industry":"","agency":"FED-HEALTH-OTHER","collection":"AGY-FED-HEALTH-OTHER","issuer":"Food and Drug Administration, HHS","instrument":"Policy for Diagnostics Testing in Laboratories Certified To Perform High Complexity Testing Under CLIA Prior to Emergency Use Authorization for Coronavirus Disease-2019 During the Public Health Emergency; Immediately in Effect Guidance, 85 Fed. Reg. 13138 (Mar. 6, 2020)","title":"Policy for Diagnostics Testing in Laboratories Certified To Perform High Complexity Testing Under the Clinical Laboratory Improvement Amendments Prior to Emergency Use Authorization for Coronavirus Disease-2019","dateIssued":"2020-02-29","startDate":"2020-02-29","endDate":"2021-09-30","quarters":["2020Q2","2020Q3","2020Q4","2021Q1","2021Q2","2021Q3"],"types":["HC","OTHER"],"grade":"primary","fileExists":true,"url":"/library/AGY-FED-HEALTH-OTHER-032","exhibitUrl":"/exhibit/AGY-FED-HEALTH-OTHER-032"},{"id":"AGY-FED-HEALTH-OTHER-012","kind":"order","level":"federal","jurisdiction":"United States (federal); Drug Enforcement Administration, Diversion Control Division","state":"","metro":"","industry":"","agency":"FED-HEALTH-OTHER","collection":"AGY-FED-HEALTH-OTHER","issuer":"Thomas W. Prevoznik, Deputy Assistant Administrator, Diversion Control Division, DEA (letter to the Healthcare Distribution Alliance)","instrument":"DEA-DC-019 (DEA066), letter granting an exception permitting transmission of DEA Form 222 by fax or scan during the COVID-19 emergency","title":"Fax/Scan 222 (final) Esign","dateIssued":"2020-03-20","startDate":"2020-03-20","endDate":"2021-09-30","quarters":["2020Q2","2020Q3","2020Q4","2021Q1","2021Q2","2021Q3"],"types":["SUPPLY","OTHER"],"grade":"primary","fileExists":true,"url":"/library/AGY-FED-HEALTH-OTHER-012","exhibitUrl":"/exhibit/AGY-FED-HEALTH-OTHER-012"},{"id":"AGY-FED-HEALTH-OTHER-099","kind":"order","level":"federal","jurisdiction":"United States (federal); Department of Agriculture, Food and Nutrition Service","state":"","metro":"","industry":"","agency":"FED-HEALTH-OTHER","collection":"AGY-FED-HEALTH-OTHER","issuer":"Food and Nutrition Service, USDA","instrument":"Notice, Agency Information Collection Activities: Supplemental Nutrition Assistance Program Emergency Allotments (COVID-19), 85 Fed. Reg. 52940 (Aug. 27, 2020)","title":"Agency Information Collection Activities: Supplemental Nutrition Assistance Program Emergency Allotments (COVID-19)","dateIssued":"2020-08-27","startDate":"2020-08-27","endDate":"2020-09-30","quarters":["2020Q3"],"types":["OTHER","EMER"],"grade":"primary","fileExists":true,"url":"/library/AGY-FED-HEALTH-OTHER-099","exhibitUrl":"/exhibit/AGY-FED-HEALTH-OTHER-099"}],"facets":{"kind":[{"value":"order","label":"Order","count":10}],"level":[{"value":"federal","label":"Federal","count":10}],"state":[],"type":[{"value":"EMER","label":"Emergency declaration","count":6},{"value":"OTHER","label":"Other","count":6},{"value":"SUPPLY","label":"Supply chain","count":5},{"value":"HC","label":"Health care orders","count":4},{"value":"TELE","label":"Telework mandate","count":1}],"quarter":[{"value":"2020Q3","label":"2020 Q3","count":10},{"value":"2020Q2","label":"2020 Q2","count":9},{"value":"2020Q4","label":"2020 Q4","count":9},{"value":"2021Q1","label":"2021 Q1","count":9},{"value":"2021Q2","label":"2021 Q2","count":9},{"value":"2021Q3","label":"2021 Q3","count":9}],"grade":[{"value":"primary","label":"Primary source read","count":10}],"industry":[],"agency":[{"value":"FED-HEALTH-OTHER","label":"Other federal health agencies","count":10}]}}